Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?

참고문헌 (13)

1. Marcellin P, "Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B", N Engl J Med, 359, pp.2442~2455 (2008)
2. Marcellin P, "Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study", Lancet, 381, pp.468~475 (2013)
3. Liaw YF, "Lamivudine for patients with chronic hepatitis B and advanced liver disease", N Engl J Med, 351, pp.1521~1531 (2004)
4. Seto WK, "Outcome of lamivudine-resistant chronic hepatitis B after up to 5 years of combination therapy with adefovir", Antivir Ther, 17, pp.1255~1262 (2012)
5. 김효진, "Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients", The Korean Journal of Internal Medicine, 30(1), pp.32~41 (2015), 대한내과학회[DOI]
6. European Association for the Study of the Liver, "EASL clinical practice guidelines: management of chronic hepatitis B virus infection", J Hepatol, 57, pp.167~185 (2012)
7. Qi X, "In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents", Antivir Ther, 12, pp.355~362 (2007)
8. Korean Association for the Study of the Liver, "KASL Clinical Practice Guidelines: management of chronic hepatitis B", Clin Mol Hepatol, 18, pp.109~162 (2012)
9. Lok AS, "Chronic hepatitis B: update 2009", Hepatology, 50, pp.661~662 (2009)
10. van Bommel F, "Longterm efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside", nucleotide analogues, 2010, pp.51, 73~80
11. Fung S, "Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B", Gastroenterology, 146, pp.980~988 (2014)
12. Lim YS, "Randomized trial of tenofovir monotherapy versus tenofovir plus entecavir combination therapy in chronic hepatitis B patients with genotypic resistance mutations to adefovir", J Hepatol, 60(1 Suppl), pp.S431~ (2014)
13. Kwon SY, "Tenofovir is effective alone or with entecavir in entecavir-resistant patients with chronic-hepatitis B virus infection: multicenter randomized trial", Clin Mol Hepatol, 20, pp.S5~ (2014)

관련 논문AI추천